
    
      This study is 8 weeks long, with an optional additional 8 weeks. The study is
      placebo-controlled and patients are randomized to receive either ropinerol or placebo.
      Changes in depression, anxiety and overall psychiatric symptoms will be monitored during
      participation.
    
  